Dilaudid (hydromorphone) is typically detectable in urine for 2 to 4 days after your last dose, though the exact window depends on the formulation you took, your kidney and liver function, and the type of test used. The drug’s pain-relieving effects wear off long before it clears from your body entirely, so understanding the difference between how long it works and how long it’s detectable matters.
How Quickly Dilaudid Wears Off
Immediate-release Dilaudid tablets start working within about 30 minutes and provide pain relief for 3 to 4 hours. The intravenous form acts much faster, kicking in within 5 minutes, peaking at 8 to 20 minutes, but lasting only 1 to 2 hours. That short duration of action is why immediate-release Dilaudid is typically dosed every 4 to 6 hours.
The extended-release version (sold as Exalgo) works on a completely different timeline. Plasma concentrations rise gradually over 6 to 8 hours and stay elevated for 18 to 24 hours after a single dose, with peak levels arriving around 12 to 16 hours. This version is designed for once-daily dosing and keeps the drug circulating in your blood much longer than standard Dilaudid.
Half-Life and Full Elimination
A drug’s half-life tells you how long it takes your body to clear half the dose from your bloodstream. For immediate-release Dilaudid in someone with normal kidney function, the half-life is roughly 2 to 3 hours. The extended-release form has a mean half-life of about 11 hours, ranging from 8 to 15 hours in most people.
It generally takes 4 to 5 half-lives for a drug to be effectively eliminated from your blood. That means immediate-release Dilaudid clears your bloodstream in roughly 10 to 15 hours, while the extended-release version can take 2 to 3 days. But “cleared from the blood” and “undetectable on a drug test” are two different things, because your body converts hydromorphone into metabolites that linger longer than the drug itself.
What Happens to Dilaudid in Your Body
Your liver does most of the work breaking down hydromorphone. The primary pathway is a process called glucuronidation, which converts the drug into a metabolite called hydromorphone-3-glucuronide. This metabolite circulates at concentrations 35 to 40 times higher than the original drug. About 75% of each dose is eventually excreted through urine, mostly as these metabolites. Only about 7% leaves your body as unchanged hydromorphone in urine, and roughly 1% through feces.
This matters for drug testing because tests can detect both the parent drug and its metabolites. Even after hydromorphone itself has cleared your blood, the much higher concentrations of its metabolite can keep you testing positive.
Detection Windows by Test Type
Different drug tests have different sensitivity levels and detection windows. Here’s what to expect for each:
- Urine: The most common screening method. Hydromorphone is generally detectable for 2 to 4 days after your last dose. Federal workplace testing uses an initial screening cutoff of 300 ng/mL for hydrocodone/hydromorphone combined, then a confirmatory cutoff of 100 ng/mL specifically for hydromorphone. Higher doses or extended-release formulations push detection toward the longer end of that range.
- Blood: Hydromorphone is detectable in blood for roughly 12 to 24 hours after an immediate-release dose. Blood tests are rarely used for routine screening because the window is so short, but they may be used in hospital or emergency settings.
- Saliva (oral fluid): Detectable for approximately 1 to 2 days. Oral fluid testing uses a lower initial cutoff of 30 ng/mL and a confirmatory threshold of 15 ng/mL, making it more sensitive per volume than urine testing.
- Hair: Like most drugs, hydromorphone can be detected in hair follicle tests for up to 90 days. Hair testing reflects longer-term use patterns rather than a single dose.
What Makes It Stay Longer
Several factors can slow your body’s ability to clear Dilaudid, extending both the duration of its effects and how long it shows up on tests.
Kidney function has the biggest impact. Your kidneys handle the bulk of excretion, and in people with severe kidney impairment, the elimination half-life can jump from around 15 hours to roughly 40 hours. That’s nearly triple the clearance time. The primary metabolite also accumulates between dialysis sessions in people with kidney failure, which further prolongs detectability.
Because the liver is responsible for metabolizing hydromorphone, significant liver disease can slow the breakdown process and keep the drug circulating longer. Body composition plays a role as well. People with higher body fat percentages, older adults, and those with slower metabolisms generally take longer to eliminate drugs. Hydration levels affect how quickly your kidneys can flush metabolites through urine.
Dose and duration of use also matter. Someone who took a single 2 mg tablet will clear the drug much faster than someone who has been taking 8 mg extended-release tablets daily for months. Chronic use allows the drug to accumulate in tissues, creating a reservoir that takes longer to fully eliminate.
Dilaudid on Standard Drug Panels
Standard workplace drug tests (the typical 5-panel screen) test for opiates, but the story is more complicated than it sounds. Older immunoassay screening tests were designed primarily to detect morphine and codeine. Hydromorphone is a semi-synthetic opioid that these older tests sometimes miss or detect inconsistently. Many modern panels now specifically include hydromorphone and hydrocodone, and expanded 10- or 12-panel tests almost always do.
If you have a valid prescription for Dilaudid and test positive, providing documentation of your prescription to the medical review officer (the physician who oversees the testing process) typically resolves the result. The positive test alone doesn’t distinguish between prescribed use and misuse, so the verification step exists for exactly this situation.
Extended-Release vs. Immediate-Release Clearance
The formulation you take significantly changes how long hydromorphone stays in your system. Immediate-release Dilaudid hits peak blood levels in about 45 minutes and is largely cleared within a day. Extended-release Exalgo takes 12 to 16 hours just to reach peak concentration, and its 11-hour average half-life means the drug is still being actively absorbed and circulating for well over two days after a single dose.
At steady state (after taking extended-release tablets daily for several days), the total drug exposure is roughly equivalent between the two formulations at the same daily dose. But the extended-release form maintains more stable blood levels rather than the peaks and valleys of the immediate-release version. This means that after stopping extended-release hydromorphone, the decline is more gradual and detection windows are correspondingly longer, potentially adding an extra 1 to 2 days of detectability compared to the immediate-release form.